About Agilent Technologies, Inc. 
Agilent Technologies, Inc.
Pharmaceuticals & Biotechnology
Agilent Technologies, Inc. provides application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company serves the life sciences, diagnostics and applied chemical markets. It has three business segments: life sciences and applied markets business, diagnostics and genomics business, and Agilent CrossLab business. Its life sciences and applied markets business segment offers instruments and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products, as well as enable customers in the clinical and life sciences research areas to interrogate samples at the molecular level. Its diagnostics and genomics business segment includes the reagent partnership, pathology, companion diagnostics, genomics and the nucleic acid solutions businesses. Its Agilent CrossLab business segment spans the entire lab with its consumables and services portfolio.
Company Coordinates 
Company Details
5301 Stevens Creek Blvd , SANTA CLARA CA : 95051-7201
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 154 Schemes (40.2%)
Foreign Institutions
Held by 462 Foreign Institutions (29.94%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Boon Hwee Koh
Non-Executive Independent Chairman of the Board
Mr. Michael McMullen
President, Chief Executive Officer, Director
Ms. Mala Anand
Independent Director
Mr. Hans Bishop
Independent Director
Mr. Paul Clark
Independent Director
Ms. Heidi Kunz
Independent Director
Revenue and Profits:
Net Sales:
1,738 Million
(Quarterly Results - Jul 2025)
Net Profit:
336 Million
Pharmaceuticals & Biotechnology
USD 36,325 Million (Mid Cap)
25.00
NA
39.43%
0.29
20.80%
5.70






